CTGF knockout does not affect cardiac hypertrophy and fibrosis formation upon chronic pressure overload

被引:39
|
作者
Fontes, Magda S. C. [1 ]
Kessler, Elise L. [1 ]
van Stuijvenberg, Leonie [1 ]
Brans, Maike A. [1 ]
Falke, Lucas L. [2 ]
Kok, Bart [1 ]
Leask, Andrew [3 ]
van Rijen, Harold V. M. [1 ]
Vos, Marc A. [1 ]
Goldschmeding, Roel [2 ]
van Veen, Toon A. B. [1 ]
机构
[1] Univ Med Ctr Utrecht, Dept Med Physiol, Div Heart & Lungs, Utrecht, Netherlands
[2] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands
[3] Univ Western Ontario, Dept Dent, London, ON N6A 3K7, Canada
关键词
CTGF; Fibrosis; Hypertrophy; Arrhythmias; TISSUE GROWTH-FACTOR; CX43; EXPRESSION; TGF-BETA; CCN2; DYSFUNCTION; CONDUCTION; MYOCYTES;
D O I
10.1016/j.yjmcc.2015.09.015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: One of the main contributors to maladaptive cardiac remodeling is fibrosis. Connective tissue growth factor (CTGF), a matricellular protein that is secreted into the cardiac extracellular matrix by both cardiomyocytes and fibroblasts, is often associated with development of fibrosis. However, recent studies have questioned the role of CTGF as a pro-fibrotic factor. Therefore, we aimed to investigate the effect of CTGF on cardiac fibrosis, and on functional, structural, and electrophysiological parameters in a mouse model of CTGF knockout (1(0) and chronic pressure overload. Methods and results: A new mouse model of global conditional CTGF KO induced by tamoxifen-driven deletion of CTGF, was subjected to 16 weeks of chronic pressure overload via transverse aortic constriction (TAC, control was sham surgery). CTGF KO TAC mice presented with hypertrophic hearts, and echocardiography revealed a decrease in contractility on a similar level as control TAC mice. Ex vivo epicardial mapping showed a low incidence of pacing-induced ventricular arrhythmias (2/12 in control TAC vs. 0/10 in CTGF MO TAC, n.s.) and a tendency towards recovery of the longitudinal conduction velocity of CTGF KO TAC hearts. Picrosirius Red staining on these hearts unveiled increased fibrosis at a similar level as control TAC hearts. Furthermore, genes related to fibrogenesis were also similarly upregulated in both TAC groups. Histological analysis revealed an increase in fibronectin and vimentin protein expression, a significant reduction in connexin43 (0;43) protein expression, and no difference in Na(v)1.5 expression of CTGF MO ventricles as compared with sham treated animals. Conclusion: Conditional CTGF inhibition failed to prevent TAC-induced cardiac fibrosis and hypertrophy. Additionally, no large differences were found in other parameters between CTGF MO and control TAC mice. With no profound effect of CTGF on fibrosis formation, other factors or pathways are likely responsible for fibrosis development. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:82 / 90
页数:9
相关论文
共 50 条
  • [41] The Natural Product Zerumbone Suppresses Pressure Overload-Induced Cardiac Dysfunction by Inhibiting Cardiac Hypertrophy and Fibrosis
    Tojima, Mikuto
    Katanasaka, Yasufumi
    Shimizu, Satoshi
    Funamoto, Masafumi
    Shimizu, Kana
    Sunagawa, Yoichi
    Hasegawa, Koji
    Morimoto, Tatsuya
    CIRCULATION, 2021, 144
  • [42] EFFECT OF CAPTOPRIL ON THE PREVENTION AND REGRESSION OF MYOCARDIAL-CELL HYPERTROPHY AND INTERSTITIAL FIBROSIS IN PRESSURE OVERLOAD CARDIAC-HYPERTROPHY
    ROSSI, MA
    PERES, LC
    AMERICAN HEART JOURNAL, 1992, 124 (03) : 700 - 709
  • [43] Protective effect of antioxidant Tempol on cardiac stem cells in chronic pressure overload hypertrophy
    Saheera, Sherin
    Potnuri, Ajay Godwin
    Nair, Renuka R.
    LIFE SCIENCES, 2019, 222 : 88 - 93
  • [44] The effect of ACE-inhibition on cardiac myocyte apoptosis in chronic pressure overload hypertrophy
    Mayer, B
    Simon, J
    Böcker, W
    Grimm, D
    Riegger, GAJ
    Schunkert, H
    EUROPEAN HEART JOURNAL, 2000, 21 : 125 - 125
  • [45] Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice
    Suzuki, Kota
    Satoh, Kimio
    Ikeda, Shohei
    Sunamura, Shinichiro
    Otsuki, Tomohiro
    Satoh, Taijyu
    Kikuchi, Nobuhiro
    Omura, Junichi
    Kurosawa, Ryo
    Nogi, Masamichi
    Numano, Kazuhiko
    Sugimura, Koichiro
    Aoki, Tatsuo
    Tatebe, Shunsuke
    Miyata, Satoshi
    Mukherjee, Rupak
    Spinale, Francis G.
    Kadomatsu, Kenji
    Shimokawa, Hiroaki
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36 (04) : 636 - 646
  • [46] Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis
    Johanna Schneider
    Achim Lother
    Lutz Hein
    Ralf Gilsbach
    Basic Research in Cardiology, 2011, 106 : 591 - 602
  • [47] Chronic cardiac pressure overload induces adrenal medulla hypertrophy and increased catecholamine synthesis
    Schneider, Johanna
    Lother, Achim
    Hein, Lutz
    Gilsbach, Ralf
    BASIC RESEARCH IN CARDIOLOGY, 2011, 106 (04) : 591 - 602
  • [48] Deletion of PPARα results in more pronounced cardiac hypertrophy in response to chronic pressure overload
    Smeets, Pascal J. H.
    Willemsen, Peter H.
    Brouns, Agnieszka E.
    Janssen, Ben J.
    van der Vusse, Ger J.
    van Bilsen, Marc
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S130 - S130
  • [49] The effect of ACE-inhibition on cardiac myocyte apoptosis in chronic pressure overload hypertrophy
    Mayer, B
    Simon, J
    Böcker, W
    Grimm, D
    Riegger, G
    Schunkert, H
    JOURNAL OF HYPERTENSION, 2000, 18 : S29 - S29
  • [50] Pressure-overload hypertrophy in cPLA2 knockout mice
    Haq, SE
    Tao, JZ
    Michael, A
    Rosenzweig, A
    Force, T
    CIRCULATION, 2000, 102 (18) : 134 - 134